Skip to content

Clinical trials

Phase 2 Eczema trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eczema Phase: Phase 2 Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20151
20182
20193
20212
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
National Institute of Allergy and Infectious Diseases (NIAID)2
Amgen1
AnaptysBio, Inc.1
AstraZeneca1
Kari Nadeau, MD, PhD1
Kymab Limited1
Pfizer1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eczema12
Dermatitis, Atopic10
Dermatitis4
Food Hypersensitivity3
Egg Hypersensitivity2
Hypersensitivity2
Pruritus2
Anaphylaxis1
Inflammation1
Peanut Hypersensitivity1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.